Sino Biopharmaceutical Limited SBMFF
0.67 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
0.6509 Day range 0.6509
0.593 52-week range 0.891
- YTD
- -23.74%
- 1 year
- -22.85%
News
reuters.com Sino Biopharmaceutical, GSK expand alliance with China rights to respiratory drugs Hong Kong-listed drugmaker Sino Biopharmaceutical said on Wednesday its China unit had secured rights to market two respiratory drugs from British company GSK in mainland China.
wsj.com AstraZeneca, Sino Biopharm Sign Up to $1.9 Billion Respiratory Drug Licensing Deal Sino Biopharmaceutical will receive $200 million upfront from AstraZeneca, and will be eligible for milestone payments.
reuters.com Hong Kong-listed Sino Biopharma, AstraZeneca sign respiratory drug deal worth up to $1.9 billion Hong Kong-listed Sino Biopharmaceutical said on Wednesday it has granted AstraZeneca the rights to develop a drug designed to treat chronic respiratory diseases outside China for total payments…
reuters.com Sino Biopharmaceutical to divest 67% stake in unit CP Qingdao for $253 mln Hong Kong-listed Sino Biopharmaceutical will sell a 67% stake in unit CP Pharmaceutical (Qingdao) for 1.82 billion yuan ($253.28 million) to entities controlled by state-owned Guoxin Group, the…
forbes.com Chinese Company Gets FDA Approval For Drug To Fight Chemotherapy Nausea Cancer killed far more people around the world than Covid-19 in 2020